Market Insights on Ocular Drug Delivery System covering sales outlook, demand forecast & up-to-date key trends
As per a study by Future Market Insight (FMI), the global ocular drug delivery system market size is likely to surpass a valuation of US$ 14.47 billion by the end of 2021, growing at a CAGR of 6.8% between 2021 and 2031. By 2031, ocular drug delivery systems sales are expected to reach US$ 27.82 billion.
The primary factor driving ocular drug delivery systems adoption is the increasing incidence of ophthalmic diseases and injuries. In the U.S., around 2,000 workers requires medical assistance due job-related eye injuries every day, according to a report published by the National Institute for Occupational Safety and Health (NIOSH).
Also, over 12 million people aged above 40 years have vision impairment in the country. Thus, the demand for effective treatment to curb the rising incidence of ophthalmic diseases and injuries is expected to create growth opportunities for the market.
Ocular drug delivery system companies are aiming at developing new products to enhance the potency of spatiotemporal drug administration. For instance, pSivida Corp. is focusing on launching its new product named, Durasert, a uveitis implant for the treatment of posterior uneitis infection. These ongoing improvements in treatment for ophthalmic diseases will favor the market growth over the assessment period.
"Increasing adoption of novel drug delivery technologies such as micro- and nanoparticles and implantable devices for posterior eye therapy is anticipated to open the floodgates for advanced ocular drug treatments," says the FMI analyst.
To remain ‘ahead’ of your competitors, request a report sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-6027
Key Takeaways
Key Drivers
Key Restraints
Competitive Landscape
Leading ocular drug delivery system manufacturers are focusing on engaging in strategic collaborations and developing new products to maintain their lead in the market. For instance,
Get a Customized Scope to Match Your Need Ask an Expert – Ask from an expert @
https://www.futuremarketinsights.com/ask-question/rep-gb-6027
Some of the leading companies operating in the ocular drug delivery system market profiled by FMI are:
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce)
Ocular Drug Delivery System Market , Ocular Drug Delivery System Market Size , Ocular Drug Delivery System , Global Ocular Drug Delivery System Market
Jun 30, 2022